Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Department of MedicineDocument Type
Journal ArticlePublication Date
2021-05-14Keywords
Kupffer cellsextracellular vesicles
inflammation
liver fibrosis
locked nucleic acid
microRNA-132
Cell Biology
Cellular and Molecular Physiology
Digestive System Diseases
Gastroenterology
Metadata
Show full item recordAbstract
microRNAs (miRs) are small regulatory RNAs that are frequently deregulated in liver disease. Liver fibrosis is characterized by excessive scarring caused by chronic inflammatory processes. In this study, we determined the functional role of miR-132 using a locked nucleic acid (LNA)-anti-miR approach in liver fibrosis. A significant induction in miR-132 levels was found in mice treated with CCl4 and in patients with fibrosis/cirrhosis. Inhibition of miR-132 in mice with LNA-anti-miR-132 caused decreases in CCl4-induced fibrogenesis and inflammatory phenotype. An attenuation in collagen fibers, alpha SMA, MCP1, IL-1beta, and Cox2 was found in LNA-anti-miR-132-treated mice. CCl4 treatment increased caspase 3 activity and extracellular vesicles (EVs) in control but not in anti-miR-132-treated mice. Inhibition of miR-132 was associated with augmentation of MMP12 in the liver and Kupffer cells. In vivo and in vitro studies suggest miR-132 targets SIRT1 and inflammatory genes. Using tumor cancer genome atlas data, an increase in miR-132 was found in hepatocellular carcinoma (HCC). Increased miR-132 levels were associated with fibrogenic genes, higher tumor grade and stage, and unfavorable survival in HCC patients. Therapeutic inhibition of miR-132 might be a new approach to alleviate liver fibrosis, and treatment efficacy can be monitored by observing EV shedding.Source
Momen-Heravi F, Catalano D, Talis A, Szabo G, Bala S. Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice. Mol Ther Nucleic Acids. 2021 May 14;25:155-167. doi: 10.1016/j.omtn.2021.05.007. PMID: 34458001; PMCID: PMC8368790. Link to article on publisher's site
DOI
10.1016/j.omtn.2021.05.007Permanent Link to this Item
http://hdl.handle.net/20.500.14038/42726PubMed ID
34458001Related Resources
Rights
Copyright 2021 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1016/j.omtn.2021.05.007
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright 2021 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).